Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection. Different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma

Journal of Clinical Investigation

Volumn 99, Issue 7, 1997, Pages 1525-1533

  Kersten, Marie José ^a   Klein, Michèl R ^a   Holwerda, Agnes M ^a   Miedema, Frank ^a,b   Van Oers, Marinus H J ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

EBV specific cytotoxic T cells; HIV 1 infection; HIV 1 specific cytotoxic T cells; non Hodgkin's lymphoma

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

EID: 0030937230     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119315     Document Type: Article

References (34)

1. Miller, G. 1990. Epstein-Barr virus: biology, pathogenesis, and medical aspects. In Virology. 2nd ed. B.N. Fields, D.M. Knipe, editors. Raven Press, New York. 1921-1958.
2. Rickinson, A.B. 1990. Cellular immunological responses to the virus infection. In The Epstein-Barr Virus: Recent Advances. M.A. Epstein, B.G. Achong, editors. John Wiley & Sons, New York. 75-115.
3. Purtilo, D.T., R.S. Strobach, M. Okano, and J.R. Davis. 1992. Epstein-Barr virus-associated lymphoproliferative disorders. Lab. Invest. 67:5-23.
4. Cohen, J.I. 1991. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine (Baltimore). 70:137-160.
5. Shibata, D., L. Weiss, A. Hernandez, B. Nathwani, L. Bernstein, and A.A.M. Levine. 1993. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood. 81:2102-2109.
6. McClain, K.L., C.T. Leach, H.B. Jenson, V.V. Joshi, B.H. Pollock, R.T. Parmley, F.J. Dicarlo, E. Gould Chadwick, and S.B. Murphy. 1995. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N. Engl. J. Med. 332:12-18.
7. Hamilton-Dutoit, S.J., G. Pallesen, and M.B. Franzmann. 1991. AIDS-related lymphoma. Histopathology, immunophenotype and association with Epstein-Barr virus, as demonstrated by in situ hybridisation. Am. J. Pathol. 138: 149-163.
8. Birx, D.L., R.R. Redfield, and G. Tosato. 1986. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N. Engl. J. Med. 314:874-879.
9. Blumberg, R.S., T. Paradis, R. Byington, W. Henle, M.S. Hirsch, and R.T. Schooley. 1987. Effects of Human Immunodeficiency Virus on the cellular immune response to Epstein-Barr Virus in homosexual men: characterization of the cytotoxic response and lymphokine production. J. Infect. Dis. 155:877-890.
10. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL response to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
11. Geretti, A.M., M.E.M. Dings, C.A.C.M. van Els, C.A. van Baalen, F.J. Wijnholds, J.C.C. Borleffs, and A.D.M.E. Osterhaus. 1996. Human immunodeficiency virus type 1 (HIV-1)- and Epstein-Barr Virus-specific T lymphocyte precursors exhibit different kinetics in HIV-1-infected persons. J. Infect. Dis. 174:34-45.
12. Klein, M.R., C. van Baalen, A.M. Holwerda, S.R. Kerkhof Garde, R.J. Bende, I.P.M. Keet, J.K.M. Eeftinck Schattenkerk, A.D.M.E. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181: 1365-1372.
13. Schellekens, P.T.A., M.T.L. Roos, F. de Wolf, J.M.A. Lange, and F. Miedema. 1990. Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for AIDS in HIV-1 infected men. J. Clin. Immunol. 10:121-127.
14. Rautmann, G., M.P. Kieny, R. Brandely, K. Dott, M. Girard, L. Montagnier, and J.P. Lecocq. 1989. HIV-1 core proteins expressed from recombinant vaccinia viruses. AIDS Res. Hum. Retroviruses. 5:147-157.
15. 8+ T cells from seropositive individuals: Identification of CTL epitopes and precursor frequencies. AIDS (Philadelphia). 7:781-786.
16. Lefkovits, I., and H. Waldmann. 1974. Poison distribution. In Limiting Dilution Analysis of Cells in the Immune System. Cambridge University Press, Cambridge. 38-59.
17. Bourgault, I., A. Gomez, E. Gomard, and J.P. Levy. 1991. Limiting dilution analysis of the HLA restriction of anti-Epstein Barr virus-specific cytolytic T lymphocytes. Clin. Exp. Immunol. 84:501-507.
18. Strijbosch, L.W.G., W.A. Buurman, R.J.M.M. Does, P.H. Zinken, and G. Groenewegen. 1987. Limiting dilution assays. Experimental design and statistical analysis. J. Immunol. Methods. 97:133-140.
19. Khanna, R., S.R. Burrows, M.G. Kurilla, C.A. Jacob, I.S. Misko, T.B. Sculley, E. Kieff, and D.J. Moss. 1992. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 176:169-176.
20. Schuitemaker, H., M. Koot, N.A. Kootstra, M.W. Dercksen, R.E.Y. de Goede, R.P. van Steenwijk, J.M.A. Lange, J.K.M. Eeftinck Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T cell-tropic virus populations. J. Virol. 66:1354-1360.
21. Thorley-Lawson, D.A., L. Chess, and J.L. Strominger. 1977. Suppression of in vitro Epstein-Barr virus infection. J. Exp. Med. 146:495-508.
22. Yao, Q.Y., P. Ogan, M. Rowe, M. Wood, A.B. Rickinson. 1989. Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int. J. Cancer. 43:67-71.
23. Moskophidis, D., F. Lechner, H. Pircher, and R.M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (Lond.). 362:758-761.
24. Ho, D.D., A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (Lond.). 373:123-126.
25. Wei, X., S.K. Ghosh, M.E. Taylor, V.A. Johnson, E.A. Emini, P. Deutsch, J.D. Lifson, S. Bonhoeffer, M.A. Nowak, B.H. Hahn et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (Lond.). 373:117-122.
26. Fishwild, D.M., C.J. Benike, and E.G. Engleman. 1988. Activation of HLA-restricted EBV-specific cytotoxic T cells does not require CD4+ (helper) T cells or exogenous cytokines. J. Immunol. 140:1994-1998.
27. + T helper cells in generating EBV and HIV specific CTL responses. Proc. Eur. Immunol. Meet., 12th, Barcelona. 470(Abstr.).
28. Matsuda, M., F. Salazar, M. Petersson, G. Masucci, J. Hansson, P. Pisa, Q.J. Zhang, M.G. Masucci, and R. Kiessling. 1994. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and down-regulates HLA Class I expression. J. Exp. Med. 180:2371-2376.
29. Meyaard, L., S.A. Otto, R.R. Jonker, M.J. Mijnster, I.P.M. Keet, and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science (Wash. DC). 257:217-219.
30. Levine, A.M. 1992. Acquired immunodeficiency syndrome related lymphoma. Blood. 80:8-20.
31. Northfelt, D.W., and L.D. Kaplan. 1991. Clinical manifestations and treatment of HIV-related non-Hodgkin's lymphoma. Cancer Surv. 10:121-133.
32. Rooney, C.M., C.A. Smith, C.Y.C. Ng, S. Loftin, C. Li, R.A. Krance, M.K. Brenner, and H.E. Heslop. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 345:9-13.
33. Papadopoulos, E.B., M. Ladanyi, and D. Emanuel. 1994. Infusions of donor leukocytes to treat Epstein-Barr virus lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330:1185-1191.
34. Savoie, A., C. Perpete, L. Carpentier, J. Joncas, and C. Alfieri. 1994. Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood. 83:2715-2722.